Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2

Signal Transduct Target Ther. 2023 Apr 26;8(1):171. doi: 10.1038/s41392-023-01443-2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Humans
  • SARS-CoV-2